文献速递生殖医学

顶体素活性对接受体外受精治疗患者累积活产率的负面影响

Acrosin activity negatively influences the cumulative live birth rate in patients undergoing IVF treatment.
PubMed 文献 · Reprod Biomed Online · 2024-04-15

回顾性单中心队列研究纳入2016至2021年间启动体外受精/卵胞浆内单精子注射治疗的5704对夫妇,按顶体素活性低于25 μIU/10^6精子或≥25 μIU/10^6精子分组。校正混杂因素后,低活性组1年累积活产率显著低于高活性组(保守法48.5%对55.4%,P=0.02;乐观法63.7%对70.3%,P=0.047)。作者认为顶体素活性可作为治疗前预测累积活产率的指标以改善咨询。

要点

  • 顶体素活性低于25 μIU/10^6精子的患者1年累积活产率显著更低。
  • 保守法累积活产率48.5%对55.4%,乐观法63.7%对70.3%。
  • 作者认为顶体素活性可用于体外受精/胞浆内单精子注射前预测累积活产率以改善咨询。

核心结论

  • 低顶体素活性水平与1年累积活产率下降相关。
  • 这些发现提示顶体素活性可在启动体外受精/胞浆内单精子注射治疗前作为累积活产率的预测指标,以提升咨询效果。

研究设计与样本

  • 回顾性单中心队列研究,纳入2016至2021年间启动体外受精/胞浆内单精子注射治疗的5704对夫妇。
  • 采用改良Kennedy法通过商品化试剂盒测定顶体素活性,按低于25 μIU/10^6精子与≥25 μIU/10^6精子分为两组。
  • 主要结局为累积活产率,定义为首次取卵后1年内所有胚胎移植所获得的持续妊娠并活产,采用保守法和乐观法估计。

主要发现

  • 顶体素活性低于25 μIU/10^6精子组与≥25 μIU/10^6精子组相比,校正混杂因素后保守法累积活产率为48.5%对55.4%(P=0.02)。
  • 校正混杂因素后乐观法累积活产率为63.7%对70.3%(P=0.047),低活性组均显著低于高活性组。
  • 将顶体素活性视为连续变量时,在年轻夫妇(男女双方年龄均小于30岁)及获卵数不超过10枚的夫妇亚组中,顶体素活性与累积活产率呈显著负相关。

临床怎么用

  • 作者认为顶体素活性可在启动体外受精/胞浆内单精子注射治疗前作为累积活产率的预测指标,以提升咨询效果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Is acrosin activity related to cumulative live birth rate (CLBR) over 1 year after IVF, intracytoplasmic sperm injection (ICSI) treatment or both? DESIGN: Retrospective monocentric cohort study of 5704 couples who started IVF/ICSI treatments between 2016 and 2021. Acrosin activity was determined by a modified Kennedy method using a commercial kit. Patients were divided into two groups according to their acrosin activity: below 25 μIU/106 spermatozoa; and an acrosin activity 25 μIU/106 spermatozoa or above. Primary outcome was the CLBR, defined as an ongoing pregnancy leading to live birth that had arisen from all embryo transfers carried out within 1 year after the first ovum retrieval. Both conservative and optimistic methods were used for estimating CLBRs. RESULTS: The CLBRs of patients with an acrosin activity below 25 μIU/106 spermatozoa were found to be significantly lower than those of patients with an acrosin activity 25 μIU/106 spermatozoa or above by conservative (48.5% versus 55.4%, P = 0.02) and optimistic (63.7% versus 70.3%, P = 0.047) methods after adjusting for confounders. When acrosin activity was regarded as a continuous variable, significant negative relationships between acrosin activity and CLBR were identified in subgroups: young couples (men and women aged younger than 30 years) and couples from whom no more than 10 eggs were retrieved. CONCLUSION: Low acrosin activity levels were correlated with decreasing CLBRs over 1 year. These findings suggest that acrosin activity can be used as a predictor for CLBRs before starting IVF/ICSI treatment to enhance the effectiveness of counselling.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Zhao S, Zhang R, Wang L, et al. Acrosin activity negatively influences the cumulative live birth rate in patients undergoing IVF treatment. Reprod Biomed Online. 2024. PMID: 38901380. doi:10.1016/j.rbmo.2024.103993

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。